Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06084026 · ClinicalTrials.gov registry record
Measuring Physical Activity With ActivPal
A clinical trial of Neuromuscular Diseases, sponsored by Columbia University.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06084026: Recruiting study of Neuromuscular Diseases, sponsored by Columbia University.
NCT06084026 is a study of Neuromuscular Diseases that is actively recruiting participants, run by Columbia University. The registered enrollment target is 40 participants, below the 129-participant average among 15 other Neuromuscular Diseases trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06084026, a study of Neuromuscular Diseases, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study measures the level of physical activity in participants with neuromuscular disorders. The patient wears a small button like meter on their leg for a period of 1 week every 6 months over a period of 3 years. Participants will also have a physical exam, six minute walk test,vital signs and questionnaires.
Primary Outcome
Activity level established with Activpal meter-button like device work on thigh.
Conditions Studied
Interventions
- OTHER ActivPal
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2026-08-31 |
What NCT06084026 shows while recruiting
NCT06084026 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 129-participant average among 15 other Neuromuscular Diseases trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Neuromuscular Diseases appearing as the primary indexed condition, and to 1 intervention - of which ActivPal is the first listed.
NCT06084026 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06084026 about?
NCT06084026 is a clinical study titled "Measuring Physical Activity With ActivPal". This study measures the level of physical activity in participants with neuromuscular disorders. The patient wears a small button like meter on their leg for a period of 1 week every 6 months over a period of 3 years. Participants will also have a physical exam, six minute walk test,vital signs and ...
What is the current status of trial NCT06084026?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2020-11-01. Estimated completion is 2026-08-31.
What conditions does trial NCT06084026 study?
This clinical trial studies the following conditions: Neuromuscular Diseases.
What interventions are being tested in trial NCT06084026?
The interventions under investigation include: ActivPal (OTHER).
Who is sponsoring clinical trial NCT06084026?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06084026 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06084026's enrollment target sits among peer trials
40 11th of 15 higher than 5 of 15 other Neuromuscular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neuromuscular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RECRUITING · Phase 2
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
CIMR Neuromuscular Research Biobank
RECRUITING
-
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
RECRUITING
-
Spastic Paraplegia - Centers of Excellence Research Network
RECRUITING
-
Non-Invasive Respiratory Monitor
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI